A CCL chemokine-derived peptide (CDIP-2) exerts anti-inflammatory activity via CCR1, CCR2 and CCR3 chemokine receptors: Implications as a potential therapeutic treatment of asthma

International Immunopharmacology

Volumn 20, Issue 1, 2014, Pages 1-11

  Mendez Enriquez E ^a   Medina Tamayo, J ^a   Soldevila, G ^a   Fortoul, T I ^b   Anton, B ^c   Flores Romo, L ^d   Garcia Zepeda E A ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^d DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Allergic airway inflammation; CCL13 MCP 4; CCR3; Chemokine receptors; Chemokines; Chemotaxis

Indexed keywords

CALCIUM; CHEMOKINE; CHEMOKINE DERIVED PEPTIDE 2; CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; EOTAXIN; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ALLERGEN; ANTIINFLAMMATORY AGENT; CDIP-2 PEPTIDE; CYTOKINE; OVALBUMIN; PEPTIDE;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BONE MARROW DERIVED EOSINOPHIL; CALCIUM CELL LEVEL; CELL INFILTRATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFECT; EOSINOPHIL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE; MOUSE; MURINE MODEL; NONHUMAN; OOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; ANIMAL; BAGG ALBINO MOUSE; CHO CELL LINE; CRICETULUS; CYTOLOGY; DRUG EFFECTS; GENETICS; LUNG; LYMPH NODE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PNEUMONIA; RESPIRATORY HYPERSENSITIVITY; TUMOR CELL LINE;

ALLERGENS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CALCIUM; CELL LINE, TUMOR; CHEMOTAXIS; CHO CELLS; CRICETULUS; CYTOKINES; EOSINOPHILS; FEMALE; HUMANS; LUNG; LYMPH NODES; MICE, INBRED BALB C; OVALBUMIN; PEPTIDES; PNEUMONIA; RECEPTORS, CCR1; RECEPTORS, CCR2; RECEPTORS, CCR3; RESPIRATORY HYPERSENSITIVITY;

EID: 84895552608     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2014.01.032     Document Type: Article

References (40)

1. L. Cohn, J.A. Elias, and G.L. Chupp Asthma: mechanisms of disease persistence and progression Annu Rev Immunol 22 2004 789 815
2. A. Rot, and U.H. von Andrian Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells Annu Rev Immunol 22 2004 891 928
3. S.J. Allen, S.E. Crown, and T.M. Handel Chemokine: receptor structure, interactions, and antagonism Annu Rev Immunol 25 2007 787 820
4. S. Ying, Q. Meng, K. Zeibecoglou, D.S. Robinson, and A. Macfarlane et al. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics J Immunol 163 1999 6321 6329
5. E. Mendez-Enriquez, and E.A. Garcia-Zepeda The multiple faces of CCL13 in immunity and inflammation Inflammopharmacology 21 2013 397 406
6. E.A. Garcia-Zepeda, M.E. Rothenberg, R.T. Ownbey, J. Celestin, and P. Leder et al. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia Nat Med 2 1996 449 456
7. A.D. Luster, and M.E. Rothenberg Role of the monocyte chemoattractant protein and eotaxin subfamily of chemokines in allergic inflammation J Leukoc Biol 62 1997 620 633
8. H. Petering, R. Hochstetter, D. Kimmig, R. Smolarski, and A. Kapp et al. Detection of MCP-4 in dermal fibroblasts and its activation of the respiratory burst in human eosinophils J Immunol 160 1998 555 558
9. H. Nakamura, A.D. Luster, H. Tateno, S. Jedrzkiewicz, and G. Tamura et al. IL-4 differentially regulates eotaxin and MCP-4 in lung epithelium and circulating mononuclear cells Am J Physiol Lung Cell Mol Physiol 281 2001 L1288 L1302
10. K. Tenscher, B. Metzner, C. Hofmann, E. Schopf, and J. Norgauer The monocyte chemotactic protein-4 induces oxygen radical production, actin reorganization, and CD11b up-regulation via a pertussis toxin-sensitive G-protein in human eosinophils Biochem Biophys Res Commun 240 1997 32 35
11. G.A. McQuibban, J.H. Gong, J.P. Wong, J.L. Wallace, and I. Clark-Lewis et al. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo Blood 100 2002 1160 1167
12. R.A. Dean, J.H. Cox, C.L. Bellac, A. Doucet, and A.E. Starr et al. Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR + CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx Blood 112 2008 3455 3464
13. I. Benitez-Hernandez, E. Mendez-Enriquez, P. Ostoa, T. Fortoul, and J.A. Ramirez et al. Proteolytic cleavage of chemokines by Trypanosoma cruzi's cruzipain inhibits chemokine functions by promoting the generation of antagonists Immunobiology 215 2010 413 426
14. E. Mendez-Enriquez, Y. Melendez, F. Martinez, G. Baay, and S. Huerta-Yepez et al. CDIP-2, a synthetic peptide derived from chemokine (C-C motif) ligand 13 (CCL13), ameliorates allergic airway inflammation Clin Exp Immunol 152 2008 354 363
15. K.D. Dyer, J.M. Moser, M. Czapiga, S.J. Siegel, C.M. Percopo, and H.F. Rosenberg Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow J Immunol 181 2008 4004 4009
16. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(- Delta Delta C(T)) method Methods 25 2001 402 408
17. T. Adachi, C.H. Cui, A. Kanda, H. Kayaba, and K. Ohta et al. Activation of epidermal growth factor receptor via CCR3 in bronchial epithelial cells Biochem Biophys Res Commun 320 2004 292 296
18. J.R. White, C. Imburgia, E. Dul, E. Appelbaum, and K. O'Donnell et al. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils J Leukoc Biol 62 1997 667 675
19. P.C. Fulkerson, C.A. Fischetti, and M.E. Rothenberg Eosinophils and CCR3 regulate interleukin-13 transgene-induced pulmonary remodeling Am J Pathol 169 2006 2117 2126
20. J.E. Pease Targeting chemokine receptors in allergic disease Biochem J 434 2011 11 24
21. B. Wu, E.Y. Chien, C.D. Mol, G. Fenalti, and W. Liu et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists Science 330 2010 1066 1071
22. E.L. Wise, C. Duchesnes, P.C. da Fonseca, R.A. Allen, T.J. Williams, and J.E. Pease Small molecule receptor agonists and antagonists of CCR3 provide insight into mechanisms of chemokine receptor activation J Biol Chem 282 2007 27935 27943
23. I. Sabroe, A. Jorritsma, V.E. Stubbs, G. Xanthou, and L.A. Jopling et al. The carboxyl terminus of the chemokine receptor CCR3 contains distinct domains which regulate chemotactic signaling and receptor down-regulation in a ligand-dependent manner Eur J Immunol 35 2005 1301 1310
24. J.Z. Zhu, C.J. Millard, J.P. Ludeman, L.S. Simpson, and D.J. Clayton et al. Tyrosine sulfation influences the chemokine binding selectivity of peptides derived from chemokine receptor CCR3 Biochemistry 50 2011 1524 1534
25. M. Wolf, S. Albrecht, and C. Marki Proteolytic processing of chemokines: implications in physiological and pathological conditions Int J Biochem Cell Biol 40 2008 1185 1198
26. M.R. Mayer, and M.J. Stone Identification of receptor binding and activation determinants in the N-terminal and N-loop regions of the CC chemokine eotaxin J Biol Chem 276 2001 13911 13916
27. I. Sabroe, M.J. Peck, B.J. Van Keulen, A. Jorritsma, and G. Simmons et al. A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry J Biol Chem 275 2000 25985 25992
28. K. Blease, N.W. Lukacs, C.M. Hogaboam, and S.L. Kunkel Chemokines and their role in airway hyper-reactivity Respir Res 1 2000 54 61
29. K.J. Carpenter, J.L. Ewing, J.M. Schuh, T.L. Ness, and S.L. Kunkel et al. Therapeutic targeting of CCR1 attenuates established chronic fungal asthma in mice Br J Pharmacol 145 2005 1160 1172
30. E.A. Garcia-Zepeda, C. Combadiere, M.E. Rothenberg, M.N. Sarafi, and F. Lavigne et al. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3 J Immunol 157 1996 5613 5626
31. P. Ogilvie, G. Bardi, I. Clark-Lewis, M. Baggiolini, and M. Uguccioni Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5 Blood 97 2001 1920 1924
32. A. Mortier, J. Van Damme, and P. Proost Regulation of chemokine activity by posttranslational modification Pharmacol Ther 120 2008 197 217
33. B. Lagu, C. Gerchak, M. Pan, C. Hou, and M. Singer et al. Potent and selective CC-chemokine receptor-2 (CCR2) antagonists as a potential treatment for asthma Bioorg Med Chem Lett 17 2007 4382 4386
34. A.J. Valente, M.M. Rozek, C.J. Schwartz, and D.T. Graves Characterization of monocyte chemotactic protein-1 binding to human monocytes Biochem Biophys Res Commun 176 1991 309 314
35. S. Hemmerich, C. Paavola, A. Bloom, S. Bhakta, and R. Freedman et al. Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2 Biochemistry 38 1999 13013 13025
36. R. Martinelli, I. Sabroe, G. LaRosa, T.J. Williams, and J.E. Pease The CC chemokine eotaxin (CCL11) is a partial agonist of CC chemokine receptor 2b J Biol Chem 276 2001 42957 42964
37. P. Ogilvie, S. Thelen, B. Moepps, P. Gierschik, and A.C. da Silva Campos et al. Unusual chemokine receptor antagonism involving a mitogen-activated protein kinase pathway J Immunol 172 2004 6715 6722
38. T.R. Parody, and M.J. Stone High level expression, activation, and antagonism of CC chemokine receptors CCR2 and CCR3 in Chinese hamster ovary cells Cytokine 27 2004 38 46
39. A.S. Heiman, B.O. Abonyo, S.F. Darling-Reed, and M.S. Alexander Cytokine-stimulated human lung alveolar epithelial cells release eotaxin-2 (CCL24) and eotaxin-3 (CCL26) J Interferon Cytokine Res 25 2005 82 91
40. D. Lykouras, F. Sampsonas, A. Kaparianos, K. Karkoulias, and K. Spiropoulos Role and pharmacogenomics of TNF-alpha in asthma Mini Rev Med Chem 8 2008 934 942